drugset / Trial / NCT06106009
A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults
RandomizedSequentialDouble-blindOther
Summary
The purpose of this clinical trial is to learn if the study medicine (called PF-07976016) is safe and how it goes in and out of the body in healthy people. The study may also explore if PF-07976016 has the potential to interact with another medicine called midazolam. In addition, the study may explore how PF-07976016 goes into the body of people who have obesity.
Timeline
- Start
- 2023-10-27
- Primary completion
- 2024-08-19
- Completion
- 2024-08-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midazolam | Small molecule | — | Oral |
| Subject | PF-07976016 | Unknown | — | — |
Indications
No indication recorded.